Today, Steve Hayes, Director of Novus Medical Detox Center, presented testimony to an FDA Advisory Panel about Purdue Pharma’s application to have their new formulation of OxyContin approved for issue by the FDA.
Mr. Hayes pointed out that Purdue was asking the FDA to trust them. As one of the Advisory Panel skeptically pointed out, their scientific data supporting their reformulation was not very persuasive.
Mr. Hayes pointed out that Purdue was the same company that so misrepresented their patent application for OxyContin that a federal judge believed that terminating their actual patent was appropriate. Purdue is a company that pled guilty in 2007 to the felony of lying about the addictive nature of their product, legal heroin, to doctors and so caused the over-prescribing that led to tens of thousands of OxyContin caused deaths.
Mr. Hayes said, ”Except for the decision by the U.S. Attorney to apply a different form of justice to Purdue, this is a company that would have been out of business in 2007 and more thousands of lives would have been saved.”
Mr. Hayes asked, “How could the FDA trust that this company would not have their sales representatives promoting that their new formulation was “safe” and result in more over-prescribing and more deaths and ruined lives.”
Mr. Hayes told the panel that there would be an unintended consequence if this new formulation of OxyContin was approved. “People will think taking OxyContin, legal heroin, will give them a high but when it doesn’t work immediately, they will take another. This will result in more people suffering from respiratory depression which will lead to more and more deaths.”
Mr. Hayes concluded by stating that the Panel and the FDA should look at the www.banoxycontin website and read the comments of people who have been devastated by this criminal company.
If you or someone you know is struggling with a drug or alcohol addiction have them call Novus Medical Detox Center today at 800 505 6604 or email info@novusdetox.com.